Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",1701,48,1.73 [1.22-2.46],0.0022794563574411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1715,47,5.69 [2.76-11.75],2.585420170149092e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,1728,48,2.06 [1.24-3.40],0.0050389098072625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1487,38,2.89 [1.37-6.09],0.0053230416746457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1453,37,4.36 [2.04-9.33],0.0001450841477588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,1715,47,2.62 [1.55-4.44],0.00033847000632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,1479,37,3.06 [1.61-5.81],0.0006536854120295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,1733,49,1.47 [1.19-1.81],0.0003774938711404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,1751,50,8.77 [3.34-22.99],1.0164943334106428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,1659,43,1.64 [1.30-2.08],4.069462790485162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,1680,45,2.22 [1.44-3.43],0.0003386115965743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,1738,49,2.65 [1.58-4.44],0.0002233247090238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,1749,50,11.19 [3.95-31.72],5.590195528753174e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,1751,50,3.07 [1.76-5.34],7.295014624514548e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,1733,49,3.14 [1.90-5.20],8.320980083069513e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,1743,49,3.08 [1.47-6.44],0.0028223762150658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,1513,38,2.91 [1.55-5.47],0.0009312881107664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,1733,49,1.86 [1.21-2.88],0.0050606930791136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,1718,47,3.40 [1.76-6.56],0.0002697257646216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,1511,38,4.65 [2.00-10.77],0.0003432305168994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1469,38,4.00 [1.80-8.91],0.0006836226546176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1682,45,1.60 [1.16-2.22],0.0044868712766554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,1479,37,7.84 [2.75-22.34],0.0001178580265819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,1479,37,4.99 [1.48-16.91],0.0097458230631279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,1738,49,3.67 [2.00-6.71],2.4611294251847167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,1448,37,3.58 [1.56-8.22],0.0026315865260561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,1733,49,3.03 [2.13-4.31],7.288860695101504e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,1733,49,2.29 [1.36-3.85],0.0018507808523271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,1751,50,0.35 [0.17-0.70],0.0029749255891106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,1735,50,2.01 [1.18-3.40],0.009676448791816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,1736,48,2.47 [1.42-4.30],0.0013707865863123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,1753,50,1.99 [1.25-3.16],0.0035342623437123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,1751,50,2.27 [1.35-3.81],0.0019540672220689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,1745,50,3.28 [1.99-5.41],3.3555374233456667e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,1751,50,2.42 [1.42-4.12],0.0011453902486198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,1741,50,3.05 [1.85-5.04],1.2998340911257011e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,1751,50,2.02 [1.25-3.26],0.0039398709803267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,1710,49,2.57 [1.45-4.57],0.0012505861153635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,1741,50,3.05 [1.99-4.66],2.730361118556368e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,1726,49,3.24 [1.94-5.41],7.626223405304471e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,1748,49,3.63 [1.90-6.93],9.484686037623414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,1744,50,2.04 [1.21-3.45],0.0076311205238041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,1741,50,2.67 [1.52-4.70],0.000616231680978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,1733,49,3.43 [1.84-6.37],9.987463294181751e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1733,49,2.54 [1.33-4.84],0.0047519155496747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,1669,47,3.42 [1.63-7.19],0.0011328656434273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,1670,50,3.55 [1.63-7.72],0.0014116249275146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,1748,49,3.96 [2.13-7.39],1.4739012950186697e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,1726,49,2.24 [1.23-4.10],0.0084817278610807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,1667,47,1.94 [1.28-2.94],0.0016926318590861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,1744,49,1.66 [1.19-2.32],0.002910960047597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,1748,49,2.39 [1.35-4.24],0.0028565575607181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,1733,49,1.86 [1.27-2.72],0.001418097531225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1735,50,3.08 [2.02-4.69],1.873332043643526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1497,38,2.94 [1.66-5.22],0.0002317298100768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,1741,49,2.48 [1.60-3.84],4.963852590140754e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,1690,47,1.64 [1.25-2.16],0.0003742177078595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,1733,49,3.43 [1.72-6.83],0.0004741991888081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,1745,50,3.85 [2.19-6.78],3.0271303737463565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,1508,38,1.81 [1.21-2.72],0.0040345725103908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,1718,47,2.76 [1.32-5.77],0.0070216578933309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,1741,50,3.23 [1.64-6.38],0.0007168291769065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,1751,50,2.14 [1.27-3.62],0.0043732956006157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,1751,50,8.07 [3.15-20.66],1.364182291580726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,1732,49,0.39 [0.20-0.76],0.0053471209958023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,1734,48,8.44 [3.51-20.29],1.8680940700422911e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,1487,38,2.28 [1.27-4.11],0.0059796014239083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,1479,38,0.53 [0.33-0.86],0.0096347444743509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,1753,50,3.94 [2.44-6.35],2.087767734352021e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,1726,49,5.65 [2.85-11.22],7.373119937555236e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,1718,47,2.11 [1.25-3.54],0.0050840076334963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,1736,49,3.61 [1.92-6.79],7.030861532850263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,1726,49,0.67 [0.49-0.91],0.0095779019151714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,1741,50,2.63 [1.54-4.47],0.0003765033931737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,1738,49,4.01 [2.01-8.01],8.217941176979093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,1718,47,2.94 [1.63-5.31],0.0003368308951908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,1738,49,1.51 [1.14-2.01],0.0046763452552652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1741,50,2.99 [1.64-5.48],0.0003759279042482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,1701,48,5.15 [2.03-13.11],0.000579265158211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,1717,47,2.85 [1.91-4.25],2.812567584583705e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,1741,50,3.27 [1.75-6.11],0.0001970567053471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,1469,38,0.55 [0.38-0.81],0.0022956642224912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1733,49,3.18 [1.66-6.12],0.0005082482584186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,1722,49,2.10 [1.42-3.11],0.0002207418582979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,1725,49,0.38 [0.23-0.61],5.940250518741509e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1751,50,3.49 [2.29-5.31],5.950406719782148e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1487,38,3.36 [1.49-7.59],0.0034825295482492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,1740,50,4.39 [2.41-8.01],1.3771281745928886e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,1715,47,5.77 [3.31-10.04],5.891906511632281e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,1502,38,2.76 [1.35-5.64],0.0053578252949722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,1674,45,3.19 [1.96-5.20],2.972125937758258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,1753,50,2.82 [1.41-5.63],0.0032767560293145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",1726,49,1.43 [1.13-1.80],0.0024025316360756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",1735,50,1.47 [1.11-1.95],0.0080680826345764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",1502,38,2.53 [1.63-3.93],3.786242962031127e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",1753,50,2.00 [1.44-2.77],3.847964791952915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,1733,49,2.79 [1.53-5.09],0.000836036998908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,1735,50,4.63 [2.52-8.52],8.518761633723268e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,1487,38,1.63 [1.13-2.35],0.0086049726314785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,1746,50,1.47 [1.22-1.77],5.666312984416589e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,1748,50,1.68 [1.30-2.18],7.375218286938054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,1687,47,3.71 [1.87-7.38],0.0001820454636888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,1741,50,0.32 [0.16-0.64],0.0012053274001245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,1741,50,4.11 [1.77-9.50],0.0009692356739092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,1511,38,2.06 [1.30-3.29],0.002304068143052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1718,47,3.17 [1.60-6.28],0.0009103839112423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,1727,49,2.37 [1.30-4.32],0.0048064868842363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,1753,50,2.39 [1.70-3.37],5.837293344705847e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,1746,50,5.26 [2.68-10.33],1.3633516707825678e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,1718,47,5.31 [2.15-13.10],0.0002912855046904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,1733,49,0.76 [0.62-0.94],0.0097114912312993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,1701,48,2.02 [1.43-2.87],7.688395197291649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,1733,50,2.51 [1.51-4.16],0.0003721669507765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,1749,50,1.87 [1.45-2.42],1.5295641117890807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,1741,50,2.49 [1.37-4.52],0.0027702811226417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1726,49,2.93 [1.47-5.83],0.0022433811726295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,1751,50,2.98 [1.79-4.94],2.474817293640529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1726,47,4.11 [2.22-7.62],7.04036644228124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,1733,49,7.26 [2.53-20.87],0.0002321037785482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,1751,50,1.48 [1.21-1.82],0.0001809719487581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,1751,50,1.72 [1.25-2.38],0.0008425786409559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,1743,49,0.46 [0.27-0.81],0.006493210481948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,1716,48,2.29 [1.59-3.30],7.558887978147263e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,1734,48,2.96 [1.66-5.29],0.0002448840089316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1735,50,2.48 [1.49-4.13],0.000505239152175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,1502,38,1.59 [1.16-2.17],0.0037174504870931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,1697,49,1.48 [1.11-1.96],0.0075934979136616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,1687,47,0.38 [0.19-0.76],0.0060124603406204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,1726,50,2.07 [1.24-3.44],0.005163373033038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,1479,37,2.12 [1.30-3.47],0.0026961461582108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1506,38,2.01 [1.18-3.40],0.0096569575255113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,1748,49,4.36 [2.32-8.22],5.032021727099544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,1734,50,2.12 [1.25-3.61],0.0055553539035423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,1719,49,3.06 [1.78-5.27],5.552147188564511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,1751,50,1.80 [1.33-2.44],0.0001287044068107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1751,50,2.11 [1.23-3.63],0.0067177556320168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",1721,49,1.53 [1.15-2.05],0.0036767797597447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1726,49,2.39 [1.65-3.45],3.987288918351566e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,1714,47,4.03 [2.50-6.50],1.141648927688673e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,1506,38,1.61 [1.14-2.27],0.0063931065827536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,1726,49,2.14 [1.48-3.11],6.33371925794879e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,1728,49,2.50 [1.26-4.97],0.0085470898786755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,1506,38,2.44 [1.31-4.57],0.0051975785501258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,1677,47,1.79 [1.28-2.49],0.0006027465860612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,1687,47,0.43 [0.23-0.81],0.0092024823749105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1720,49,2.75 [1.47-5.15],0.0015629274481047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,1719,48,2.02 [1.25-3.28],0.0041519324963302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,1738,50,2.52 [1.64-3.88],2.664417745863904e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,1502,38,2.68 [1.39-5.14],0.0030938481609192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,1753,50,2.39 [1.40-4.09],0.0015075561653129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,1741,50,1.73 [1.15-2.59],0.0081199407382601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,1737,50,1.90 [1.26-2.85],0.0021063504240896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,1751,50,2.32 [1.25-4.31],0.0075164276523902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,1670,45,1.74 [1.23-2.48],0.0019341579585795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1741,50,4.62 [2.25-9.49],3.087259715149018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,1726,49,2.88 [1.63-5.09],0.0002880943795321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1487,38,3.79 [1.79-8.03],0.0004910057482289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,1751,50,4.28 [2.03-9.02],0.0001364081543723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,1735,50,2.91 [1.54-5.51],0.0010226188720993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,1741,50,2.43 [1.60-3.68],2.7924678495367504e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,1665,45,3.69 [2.52-5.40],1.879371469853093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,1741,50,0.32 [0.21-0.50],4.013679445009887e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,1751,50,2.60 [1.28-5.29],0.0080576130331369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",1670,45,2.19 [1.40-3.42],0.0005537692286654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,1491,37,3.93 [1.72-9.00],0.0011969590406283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,1735,50,2.62 [1.61-4.28],0.0001175969905447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,1751,50,1.71 [1.16-2.52],0.0066454501344573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1735,50,1.41 [1.16-1.71],0.0005218387785531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,1670,45,1.91 [1.17-3.12],0.0094644258425794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,1741,50,3.34 [2.15-5.21],9.455415034334e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,1733,49,1.90 [1.17-3.08],0.009765638961343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,1497,38,2.91 [1.58-5.36],0.0005818497485042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,1749,49,1.68 [1.14-2.46],0.0080722843800795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,1733,49,3.11 [1.46-6.61],0.0031896648178159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,1751,50,3.26 [1.65-6.46],0.0006907178427651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1718,47,4.68 [2.17-10.08],8.310911363657527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,1714,50,1.72 [1.24-2.40],0.0012339285931957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,1720,50,2.51 [1.47-4.31],0.000800755509584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1741,50,5.20 [2.99-9.06],5.694332442333567e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1741,50,2.63 [1.44-4.81],0.0016943238586141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,1502,38,4.86 [1.60-14.78],0.0053143507068856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,1741,50,0.35 [0.20-0.64],0.0005039485525195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,1719,49,3.47 [1.63-7.40],0.001234418015885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",1497,38,0.43 [0.25-0.72],0.0015093558654526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,1741,50,4.81 [2.27-10.21],4.291932317356884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1733,49,1.89 [1.17-3.06],0.0089875569967987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,1508,38,5.89 [2.65-13.12],1.4194009507922664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,1748,49,1.56 [1.23-1.98],0.0002319502417406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,1728,49,2.20 [1.30-3.75],0.0034472504889238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,1499,38,4.78 [1.75-13.05],0.0022812095936126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1718,47,1.51 [1.20-1.90],0.0005192610389079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,1724,48,3.83 [2.19-6.71],2.587545286233928e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,1670,45,3.17 [1.73-5.81],0.0001855198718052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1713,47,2.55 [1.57-4.16],0.0001566313251731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,1498,38,1.51 [1.11-2.06],0.0088023912441413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,1448,37,1.45 [1.13-1.85],0.0036815587900424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,1726,49,0.43 [0.26-0.72],0.0011277906128846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,1506,38,1.81 [1.17-2.79],0.0071859459267981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,1733,49,1.67 [1.23-2.28],0.0011555530878503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,1730,48,1.87 [1.33-2.62],0.0002711016034757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,1730,49,2.51 [1.73-3.64],1.4234728445821545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1741,50,3.33 [1.71-6.50],0.0004173515856746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,1735,50,1.49 [1.20-1.86],0.0003618491320191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,1511,38,3.86 [1.53-9.72],0.0041204255670452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,1747,50,2.48 [1.55-3.96],0.0001448548847196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,1469,38,3.51 [1.63-7.56],0.0013761693504576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,1751,50,2.67 [1.36-5.24],0.0043428932634299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,1701,48,1.65 [1.21-2.26],0.0015276194609314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,1748,49,5.25 [2.89-9.54],5.27779183570103e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,1680,46,3.38 [2.04-5.63],2.570322189774244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,1748,49,4.89 [2.43-9.85],9.024179437501008e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,1743,50,3.62 [1.98-6.63],2.976894329702498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,1735,49,1.97 [1.24-3.15],0.0043977307764901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,1687,47,2.80 [1.78-4.40],8.26642881481056e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,1714,47,2.01 [1.24-3.25],0.0046474979864217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,1508,38,3.84 [1.79-8.22],0.0005411551050615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,1670,45,1.73 [1.18-2.53],0.0045968049882555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,1670,45,1.46 [1.11-1.92],0.0066857308280658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,1751,50,3.29 [1.61-6.73],0.0011171212099082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,1738,49,2.14 [1.30-3.51],0.0025976050504285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,1718,47,1.91 [1.36-2.67],0.0001655235394771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,1682,45,2.77 [1.50-5.13],0.0011706110394719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,1741,50,1.91 [1.37-2.66],0.000140280774206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,1726,49,2.54 [1.88-3.43],1.190458829849791e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,1729,49,2.80 [1.59-4.94],0.0003652787812564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,1748,49,2.31 [1.42-3.74],0.0006800799417645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,1465,37,0.44 [0.24-0.80],0.007477165364824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,1733,49,2.71 [1.67-4.42],5.986425566401445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,1751,50,2.18 [1.29-3.71],0.0037569679473102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,1733,50,1.65 [1.30-2.09],4.5933792408612856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,1733,49,2.20 [1.59-3.04],1.986141871469732e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,1725,49,2.11 [1.53-2.90],5.659875097370885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,1741,50,2.71 [1.74-4.24],1.1447827943001576e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,1748,49,2.95 [1.46-5.95],0.0024642329797607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1718,47,5.16 [2.62-10.14],2.0307159629440165e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1718,47,1.53 [1.24-1.88],5.050207724671718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1751,50,2.65 [1.68-4.17],2.795659065906033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1741,50,3.32 [2.00-5.52],3.391872905635034e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1730,49,3.52 [2.01-6.17],1.088906751613951e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1751,50,2.87 [1.76-4.68],2.429399649540302e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1741,50,3.43 [1.86-6.31],7.775303313408917e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1741,50,1.66 [1.20-2.28],0.0019585702000708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1748,49,3.32 [1.50-7.35],0.0030859344373127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1749,50,2.43 [1.50-3.94],0.0003234765974092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1718,47,2.14 [1.43-3.19],0.0002012817880162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1718,47,2.70 [1.71-4.28],2.2593002165648105e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1738,49,5.35 [2.47-11.56],2.0070506992801443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1453,37,2.42 [1.36-4.31],0.0026184197531503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,1718,47,3.44 [1.98-5.97],1.0894160713255728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,1747,50,0.31 [0.22-0.44],2.8540815124170888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,1749,50,2.42 [1.29-4.54],0.0059878605020683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1733,49,1.78 [1.18-2.68],0.0056627697652736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1498,38,1.87 [1.32-2.66],0.0004397073926295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1737,48,2.34 [1.44-3.80],0.0005809144310844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,1711,47,3.34 [1.86-5.99],5.442865153012694e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,1749,50,1.60 [1.15-2.22],0.0050736439296828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,1652,47,2.80 [1.92-4.06],6.897629155023066e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,1743,50,3.39 [1.99-5.76],6.890317708476241e-06
